BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/AKT2/Compounds

Compounds That Target AKT2

RAC-beta serine/threonine-protein kinase · 12 compounds in BiohacksAI corpus

AKT2 (RAC-beta serine/threonine-protein kinase) is a protein kinase involved in intracellular signal transduction. Kinases phosphorylate downstream substrates to regulate cell growth, survival, and metabolism. The 12 compounds targeting AKT2 include both pharmaceutical inhibitors and natural compounds with evidence of kinase modulation, ranked by evidence strength from the BiohacksAI corpus.

View AKT2 target page →
All 12 Compounds — Ranked by Evidence
1
Midostaurin
3.85
confidence
2
Lestaurtinib
3.04
confidence
3
Ruboxistaurin
2.94
confidence
4
Mk 2206
2.83
confidence
5
Capivasertib
2.77
confidence
6
Gsk 690693
2.64
confidence
7
Ipatasertib
2.20
confidence
8
A 443654
2.20
confidence
9
Gsk 269962a
2.08
confidence
10
Uprosertib
1.95
confidence
11
Borussertib
1.95
confidence
12
Afuresertib
1.79
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for AKT2 (RAC-beta serine/threonine-protein kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: AKT2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.